Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics Previous close 25.65
Open 26.58
Day range 26.46 26.50
52-week range 23.40 27.94
Off day high −0.14%
Off 52-week high −5.28%
Volume 3.23K
Avg. volume (3M) 1.26K
Net assets 5.97M
Expense ratio 0.59%
Yield 1.59%
YTD return +3.02%
50-day average 25.47
200-day average 25.32
No recent coverage in the 4Search index.
From the 4Search news index, newest first.
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies expected to economically benefit from weight loss drug development. The index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs. The fund is non-diversified.
Fund family Amplify ETFs
Category Health
Prices may be delayed up to 15 min.
A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.
Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use . How to use Finance